Skip to main content

David Gooden

Research Scientist
Chemistry
Box 90317, Durham, NC 27708-0348
A02 Levine Science Research Center, Durham, NC 27708

Selected Grants


Development of an oral targeted drug for treatment of bartonelloses

ResearchResearch Scientist · Awarded by Steven & Alexandra Cohen Foundation · 2021 - 2025

DART2.0: comprehensive cell type-specific behavioral neuropharmacology

ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2022

Adjuvant Discovery Program (Option #3)

ResearchResearch Scientist · Awarded by National Institutes of Health · 2014 - 2020

Adjuvant Discovery Program (Option #2)

ResearchResearch Scientist · Awarded by National Institutes of Health · 2014 - 2019

Adjuvant Discovery Program (Option #1)

ResearchResearch Scientist · Awarded by National Institutes of Health · 2014 - 2017

Development of an oral targeted drug for treatment of bartonelloses

ResearchResearch Scientist · Awarded by Steven & Alexandra Cohen Foundation · 2021 - 2025

DART2.0: comprehensive cell type-specific behavioral neuropharmacology

ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2022

Adjuvant Discovery Program (Option #3)

ResearchResearch Scientist · Awarded by National Institutes of Health · 2014 - 2020

Adjuvant Discovery Program (Option #2)

ResearchResearch Scientist · Awarded by National Institutes of Health · 2014 - 2019

Adjuvant Discovery Program (Option #1)

ResearchResearch Scientist · Awarded by National Institutes of Health · 2014 - 2017

Adjuvant Discovery Program

ResearchResearch Scientist · Awarded by National Institutes of Health · 2014 - 2017